MS News That Caught My Eye Last Week: More Tysabri Benefits, Long-term Ocrevus Data, Trial Diversity, MS and the Gut
Tysabri Affects Immune System Beyond Known MS Target, Study Finds Tysabri (natalizumab) slows multiple sclerosis progression by blocking some immune cells from entering the central nervous system, where they attack the myelin coating of nerves. Yet this study shows that Tysabri may also significantly reduce the number of proteins…